{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:54:30Z","timestamp":1793235270046,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400379"],"award-info":[{"award-number":["82400379"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270335"],"award-info":[{"award-number":["82270335"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200342"],"award-info":[{"award-number":["82200342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371164"],"award-info":[{"award-number":["32371164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015401","name":"Shaanxi Province Key Research and Development Projects","doi-asserted-by":"publisher","award":["2024SF-YBXM-028"],"award-info":[{"award-number":["2024SF-YBXM-028"]}],"id":[{"id":"10.13039\/501100015401","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168438","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:55:27Z","timestamp":1787756127000},"page":"168438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1\u03b1-mediated metabolic dysregulation"],"prefix":"10.1016","volume":"1873","author":[{"given":"Lingyan","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiannan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiangsun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168438_bb0005","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbadis.2026.168438_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076246","article-title":"Management of atrial fibrillation in older adults","volume":"386","author":"Parks","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.bbadis.2026.168438_bb0015","article-title":"Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study","volume":"361","author":"Staerk","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.bbadis.2026.168438_bb0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1007\/s11357-020-00274-1","article-title":"Effect of rapamycin on aging and age-related diseases-past and future","volume":"43","author":"Selvarani","year":"2021","journal-title":"GeroScience"},{"key":"10.1016\/j.bbadis.2026.168438_bb0025","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S2666-7568(21)00062-3","article-title":"Targeting the biology of ageing with mTOR inhibitors to improve immune function in older adults: phase 2b and phase 3 randomised trials","volume":"2","author":"Mannick","year":"2021","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.bbadis.2026.168438_bb0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11357-019-00113-y","article-title":"Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial","volume":"41","author":"Chung","year":"2019","journal-title":"GeroScience"},{"key":"10.1016\/j.bbadis.2026.168438_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101376","article-title":"The role of rapamycin in healthspan extension via the delay of organ aging","volume":"70","author":"Zhang","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2026.168438_bb0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2026.168438_bb0045","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1016\/S2666-7568(23)00258-1","article-title":"Targeting ageing with rapamycin and its derivatives in humans: a systematic review","volume":"5","author":"Lee","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.bbadis.2026.168438_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158291","article-title":"Metabolic inflexibility as a pathogenic basis for atrial fibrillation","volume":"23","author":"Qin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168438_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41392-023-01378-8","article-title":"Metabolic landscape in cardiac aging: insights into molecular biology and therapeutic implications","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bbadis.2026.168438_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.carpath.2008.11.001","article-title":"Atrial fibrillation is associated with cardiac hypoxia","volume":"19","author":"Gramley","year":"2010","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.bbadis.2026.168438_bb0065","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.ijcard.2013.03.174","article-title":"The role of Toll-like receptor 2 and hypoxia-induced transcription factor-1\u03b1 in the atrial structural remodeling of non-valvular atrial fibrillation","volume":"168","author":"Xu","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bbadis.2026.168438_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113403","article-title":"Empagliflozin protects the heart from atrial fibrillation in rats through inhibiting the NF-\u03baB\/HIF-1\u03b1 regulatory axis and atrial remodeling","volume":"143","author":"Badreldin","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbadis.2026.168438_bb0075","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1161\/CIRCULATIONAHA.121.053960","article-title":"Interferon-\u03b3 impairs human coronary artery endothelial glucose metabolism by tryptophan catabolism and activates fatty acid oxidation","volume":"144","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bbadis.2026.168438_bb0080","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.261","article-title":"Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1\u03b1-modulated fatty acid metabolism","volume":"8","author":"Ni","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168438_bb0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuroscience.2025.10.010","article-title":"Astragalin rescues cadmium-induced cognitive decline by revering glial metabolic reprogramming and neuroinflammation via the mTOR\/HIF-1\u03b1 axis","volume":"588","author":"Huang","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2026.168438_bb0090","article-title":"Zhenqi Fuzheng granule targets the SCFAs-GPR109A axis to enhance PD-1 antibody efficacy via immunometabolic remodeling in colorectal cancer","volume":"148","author":"Guo","year":"2025","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.bbadis.2026.168438_bb0095","first-page":"1558","article-title":"CLT-003 exerts anti-tumor activity in pancreatic cancer by blocking the PI3K\/AKT\/HIF-1\u03b1 pathway","volume":"22","author":"Xu","year":"2025","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.bbadis.2026.168438_bb0100","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10522-019-09837-y","article-title":"D-Galactose-induced accelerated aging model: an overview","volume":"20","author":"Azman","year":"2019","journal-title":"Biogerontology"},{"key":"10.1016\/j.bbadis.2026.168438_bb0105","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41401-022-00956-w","article-title":"Tetrahydroberberrubine retards heart aging in mice by promoting PHB2-mediated mitophagy","volume":"44","author":"Wang","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbadis.2026.168438_bb0110","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1038\/s12276-024-01347-3","article-title":"SUMOylation of TP53INP1 is involved in miR-30a-5p-regulated heart senescence","volume":"56","author":"Yx","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168438_bb0115","article-title":"Enhancing fatty acids oxidation via L-carnitine attenuates obesity-related atrial fibrillation and structural remodeling by activating AMPK signaling and alleviating cardiac lipotoxicity","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168438_bb0120","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1046\/j.1540-8167.2001.01269.x","article-title":"Evolution of action potential propagation and repolarization in cultured neonatal rat ventricular myocytes","volume":"12","author":"Meiry","year":"2001","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.bbadis.2026.168438_bb0125","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbadis.2026.168438_bb0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/ars.2013.5255","article-title":"Mitochondria and metabolic homeostasis","volume":"19","author":"Cheng","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2026.168438_bb0135","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1111\/bph.16402","article-title":"The ion channel TRPM8 is a direct target of the immunosuppressant rapamycin in primary sensory neurons","volume":"181","author":"Arcas","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2026.168438_bb0140","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/onc.2009.435","article-title":"Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min\/+) mice","volume":"29","author":"Koehl","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadis.2026.168438_bb0145","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2014.09.011","article-title":"Rapamycin reveals an mTOR-independent repression of Kv11 expression during epileptogenesis","volume":"73","author":"Sosanya","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2026.168438_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ani13203184","article-title":"Multi-omic, histopathologic, and clinicopathologic effects of once-weekly oral rapamycin in a naturally occurring feline model of hypertrophic cardiomyopathy: a pilot study","volume":"13","author":"Rivas","year":"2023","journal-title":"Animals"},{"key":"10.1016\/j.bbadis.2026.168438_bb0155","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/acel.12109","article-title":"Late-life rapamycin treatment reverses age-related heart dysfunction","volume":"12","author":"Flynn","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2026.168438_bb0160","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004106","article-title":"Rapamycin attenuates cardiac fibrosis in experimental uremic cardiomyopathy by reducing marinobufagenin levels and inhibiting downstream pro-fibrotic signaling","volume":"5","author":"Haller","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.bbadis.2026.168438_bb0165","first-page":"223","article-title":"Rapamycin inhibits the mTOR\/p70S6K pathway and attenuates cardiac fibrosis in adriamycin-induced dilated cardiomyopathy","volume":"61","author":"Yu","year":"2013","journal-title":"Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bbadis.2026.168438_bb0170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cca.2019.08.029","article-title":"The Warburg effect: a new insight into atrial fibrillation","volume":"499","author":"Liu","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbadis.2026.168438_bb0175","first-page":"779","article-title":"Metabolic mechanism and intervention strategy of atrial fibrillation in the elderly","volume":"75","author":"Yang","year":"2023","journal-title":"Acta Phys. Sin."},{"key":"10.1016\/j.bbadis.2026.168438_bb0180","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1074\/jbc.M611782200","article-title":"Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif","volume":"282","author":"Land","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2026.168438_bb0185","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1158\/1078-0432.CCR-08-0889","article-title":"Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin\/hypoxia-inducible factor-1alpha axis","volume":"15","author":"Pencreach","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbadis.2026.168438_bb0190","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i9.109378","article-title":"Rapamycin suppresses small bowel adenocarcinoma HUTU 80 cells proliferation by inhibiting hypoxia-inducible factor-1\u03b1 mediated metabolic reprogramming","volume":"17","author":"Pu","year":"2025","journal-title":"World J. Gastrointest. Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926003042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:24:51Z","timestamp":1790987091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926003042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926003042"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168438","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapamycin attenuates age-related atrial remodeling and fibrillation by targeting HIF-1\u03b1-mediated metabolic dysregulation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168438"}}